EMA Discusses Pharmacovigilance with French IGAS

The European Medicines Agency hosted a meeting with the French General Inspectorate of Social Affairs to discuss the current system of the safety monitoring of medicines in the EU.

On Tuesday 17 May, the European Medicines Agency hosted a meeting with the French General Inspectorate of Social Affairs (IGAS) to discuss the current system of the safety monitoring of medicines in the European Union (EU). The meeting formed part of IGAS's ongoing review of pharmacovigilance and medicines regulation in France.

The meeting focused on:
1. the development of the systems of medicines regulation and pharmacovigilance in the EU since the Agency's establishment in 1995;
2. the initiatives taken to reinforce pharmacovigilance in the EU over recent years;
3. the opportunities provided by the new EU pharmacovigilance legislation, including strengthened pharmacovigilance and the increased promotion and protection of public health.